Ajay Major/LinkedIn
Nov 28, 2024, 16:30
Ajay Major: Bridging Radiotherapy and Systemic Therapy – Impact on Outcomes Before Axi-Cel
Ajay Major, Assistant Professor of Medicine at the University of Colorado School of Medicine, shared a post on X:
“Bridging RT v systemic tx retrospective before axi-cel ASH24:
– 98 pts, 35 RT bridging alone
– CR 85% RT, 71% chemo (not significant)
– 1-yr PFS 75% RT, 49% chemo (significant)
– MV model PFS: improved PFS (HR 0.41) with RT alone
Time for a randomized trial.”
More posts featuring Ajay Major.
Ajay Major is an Assistant Professor of Medicine at the University of Colorado School of Medicine, specializing in lymphoma and CLL/SLL. He is the Founder and President of Pager Publications, as well as the Founder and Editor-in-Chief of in-House. Additionally, he serves as a Reviewer for the Bellevue Literary Review.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 28, 2024, 15:29
Nov 28, 2024, 14:04
Nov 28, 2024, 12:51
Nov 28, 2024, 12:44
Nov 28, 2024, 12:35
Nov 28, 2024, 12:29